Evidence map›Paper›PMID 35982238›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosis.

Johanna M Schwarzer, Inga Meyhoefer, Linda A Antonucci, Lana Kambeitz-Ilankovic, Marian Surmann, Olga Bienek, Georg Romer, Udo Dannlowski, Tim Hahn, Alexandra Korda and 18 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Basic symptoms of psychosis-from historical foundations to current evidence.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The influence of deprivation on cortical development and psychotic symptoms in youth.Journal of child psychology and psychiatry, and allied disciplines · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 8 countries.

Johanna M SchwarzerInstitute for Translational Psychiatry, University of Muenster, Muenster, Germany.
Inga MeyhoeferInstitute for Translational Psychiatry, University of Muenster, Muenster, Germany.
Linda A AntonucciDepartment of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Lana Kambeitz-IlankovicDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany.
Marian SurmannInstitute for Translational Psychiatry, University of Muenster, Muenster, Germany.
Olga BienekDepartment of Child Adolescence Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany.
Georg RomerDepartment of Child Adolescence Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany.
Udo DannlowskiInstitute for Translational Psychiatry, University of Muenster, Muenster, Germany.
Tim HahnInstitute for Translational Psychiatry, University of Muenster, Muenster, Germany.
Alexandra KordaDepartment of Psychiatry and Psychotherapy, University of Luebeck, Luebeck, Germany.
Dominic B DwyerDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany.ORCID 0000-0003-3949-5867
Anne RuefDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany.
Shalaila S HaasDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-1385-1050
Marlene RosenDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Theresa LichtensteinDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Joseph KambeitzDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.ORCID 0000-0002-8988-3959
Raimo K R SalokangasDepartment of Psychiatry, University of Turku, Turku, Finland.ORCID 0000-0002-8532-1596
Christos PantelisMelbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.ORCID 0000-0002-9565-0238
Frauke Schultze-LutterDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.ORCID 0000-0003-1956-9574
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.
Paolo BrambillaDepartment of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-4021-8456
Alessandro BertolinoDepartment of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Stefan BorgwardtDepartment of Psychiatry and Psychotherapy, University of Luebeck, Luebeck, Germany.
Rachel UpthegroveInstitute for Mental Health, and Centre for Human Brain Health, School of Psychology, University of Birmingham, Birmingham, UK.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany.ORCID 0000-0001-6825-6262
Rebekka LencerInstitute for Translational Psychiatry, University of Muenster, Muenster, Germany. rebekka.lencer@uni-muenster.de.ORCID 0000-0003-4032-7297
PRONIA Consortium
Ludwig-Maximilians-Universität München · DEUniversity of Turku · FIUniversity of Basel · CHUniversity of Cologne · DECentre for Mental Health · GBHeinrich Heine University Düsseldorf · DEFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Udine · ITGeneral Electric (United States) · USAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITIRCCS Eugenio Medea · ITOspedale San Paolo · ITUniversity of Bari Aldo Moro · ITUniversity of Münster · DEIcahn School of Medicine at Mount Sinai · USKing's College London · GBThe University of Melbourne · AUUniversity Hospital Münster · DEUniversity of Bern · CHUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subtle subjective visual dysfunctions (VisDys) are reported by about 50% of patients with schizophrenia and are suggested to predict psychosis states. Deeper insight into VisDys, particularly in early psychosis states, could foster the understanding of basic disease mechanisms mediating susceptibility to psychosis, and thereby inform preventive interventions. We systematically investigated the relationship between VisDys and core clinical measures across three early phase psychiatric conditions. Second, we used a novel multivariate pattern analysis approach to predict VisDys by resting-state functional connectivity within relevant brain systems. VisDys assessed with the Schizophrenia Proneness Instrument (SPI-A), clinical measures, and resting-state fMRI data were examined in recent-onset psychosis (ROP, n = 147), clinical high-risk states of psychosis (CHR, n = 143), recent-onset depression (ROD, n = 151), and healthy controls (HC, n = 280). Our multivariate pattern analysis approach used pairwise functional connectivity within occipital (ON) and frontoparietal (FPN) networks implicated in visual information processing to predict VisDys. VisDys were reported more often in ROP (50.34%), and CHR (55.94%) than in ROD (16.56%), and HC (4.28%). Higher severity of VisDys was associated with less functional remission in both CHR and ROP, and, in CHR specifically, lower quality of life (Qol), higher depressiveness, and more severe impairment of visuospatial constructability. ON functional connectivity predicted presence of VisDys in ROP (balanced accuracy 60.17%, p = 0.0001) and CHR (67.38%, p = 0.029), while in the combined ROP + CHR sample VisDys were predicted by FPN (61.11%, p = 0.006). These large-sample study findings suggest that VisDys are clinically highly relevant not only in ROP but especially in CHR, being closely related to aspects of functional outcome, depressiveness, and Qol. Findings from multivariate pattern analysis support a model of functional integrity within ON and FPN driving the VisDys phenomenon and being implicated in core disease mechanisms of early psychosis states.

Indexed as

Psychotic DisordersSchizophreniaBrainHumansMagnetic Resonance ImagingQuality of Life

Identifiers

PMID35982238
PMCPMC9556592
OpenAlexW4292202469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.